INTERPACE BIOSCIENCES, INC. Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High
INTERPACE BIOSCIENCES, INC. (IDXGD) had Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High of $50.00 million as of 2013-12-31, per its 10-Q filed 2015-05-12.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh · last filed 2015-05-12
- 2013-12-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $50.00M; Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High as first filed $12.50M.
- 2012-12-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $12.50M.
- 2011-12-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $5.00M; Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High as first filed $12.50M.
- 2010-12-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $5.00M.
| Period end | Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High as first filed |
|---|---|---|
| 2013-12-31 | $50.00M 10-Q · filed 2015-05-12 | $12.50M 10-K · filed 2014-03-06 |
| 2012-12-31 | $12.50M 10-K · filed 2014-03-06 | |
| 2011-12-31 | $5.00M 10-K · filed 2014-03-06 | $12.50M 10-K · filed 2013-03-15 |
| 2010-12-31 | $5.00M 10-K · filed 2013-03-15 |